TY  - JOUR

T1  - Genetic material should be routinely collected in clinical vaccine trials – High consent rates can be achieved across all age groups

JO  - Vaccine

PY  - 2013/06/07

AU  - Trück J

AU  - O’Connor D

AU  - Darton TC

AU  - John TM

AU  - Snape MD

AU  - Pollard AJ

ED  - 

DO  - DOI: 10.1016/j.vaccine.2013.03.070

PB  - Elsevier BV

VL  - 31

IS  - 25

SP  - 2744

EP  - 2748

Y2  - 2024/10/18

ER  -